Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.